Nuclear Medicines are primarily drugs that contain radioactive elements for radionuclide-emitting ionizing radiations. Their core application lies in the diagnosis and treatment of various diseases that conventional medicines fail to achieve. Radiopharmaceuticals are unique as they are used to directly target specific organs sites in the body where the drug can emit radiations. These radiations are then captured by gamma cameras placed in proximity of the patient. The radiation dose in these pharmaceuticals is kept as low as possible to avoid the side effects of radiation exposure.
The Nuclear Medicine-Radiopharmaceuticals market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Nuclear Medicine-Radiopharmaceuticals industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Nuclear Medicine-Radiopharmaceuticals market can be split based on product types, major applications, and important countries as follows:
Key players in the global Nuclear Medicine-Radiopharmaceuticals market covered in Chapter 12:
Triad Isotopes, Inc. (US)
Medi-Radiopharma Ltd (Hungary)
Advanced Medical Isotope Corporation (US)
Alliance Medical (UK)
Peregrine Pharmaceuticals, Inc. (US)
Actinium Pharmaceuticals Inc (US)
Ion Beam Applications S.A (Belgium)
Mallinckrodt Pharmaceuticals (Ireland)
Siemens Healthcare (US)
Jubilant Pharma (India)
Positron Corporation (US)
Bayer HealthCare Medical Care (US)
Bracco Imaging S.p.A (Italy)
Nordion, Inc. (Canada)
Lantheus Medical Imaging Inc (US)
Avid Radiopharmaceuticals (US)
Immunomedics, Inc. (US)
Cardinal Health, Inc (US)
Alseres Pharmaceuticals, Inc (US)
GE Healthcare (UK)
In Chapter 4 and 14.1, on the basis of types, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2025 is primarily split into:
Diagnostic Medicine
Therapeutic Medicine
In Chapter 5 and 14.2, on the basis of applications, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2025 covers:
SPECT
PET
Therapeutic
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
COVID-19 Outbreak-Global Nuclear Medicine-Radiopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Table of Content
1 Nuclear Medicine-Radiopharmaceuticals Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Nuclear Medicine-Radiopharmaceuticals
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Nuclear Medicine-Radiopharmaceuticals industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Nuclear Medicine-Radiopharmaceuticals Market Size, 2015 - 2020
2.1.2 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Type, 2015 - 2020
2.1.3 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Application, 2015 - 2020
2.1.4 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Nuclear Medicine-Radiopharmaceuticals Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Nuclear Medicine-Radiopharmaceuticals Analysis
3.2 Major Players of Nuclear Medicine-Radiopharmaceuticals
3.3 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
3.3.3 Labor Cost of Nuclear Medicine-Radiopharmaceuticals
3.4 Market Distributors of Nuclear Medicine-Radiopharmaceuticals
3.5 Major Downstream Buyers of Nuclear Medicine-Radiopharmaceuticals Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Nuclear Medicine-Radiopharmaceuticals Market, by Type
4.1 Global Nuclear Medicine-Radiopharmaceuticals Value and Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate by Type (2015-2020)
4.3.1 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate of Diagnostic Medicine
4.3.2 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate of Therapeutic Medicine
4.4 Global Nuclear Medicine-Radiopharmaceuticals Price Analysis by Type (2015-2020)
5 Nuclear Medicine-Radiopharmaceuticals Market, by Application
5.1 Downstream Market Overview
5.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of SPECT (2015-2020)
5.3.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of PET (2015-2020)
5.3.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of Therapeutic (2015-2020)
6 Global Nuclear Medicine-Radiopharmaceuticals Market Analysis by Regions
6.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Regions
6.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)
6.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue by Regions (2015-2020)
6.2 North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7 North America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
7.2.1 North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
7.2.2 North America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
7.3 United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
8.2.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
8.2.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
8.3 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.4 UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.5 France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.6 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.7 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.8 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
9.2.2 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
9.3 China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.6 India Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.8 Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
10.3 Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.4 UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.5 Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.6 Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.7 South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11 South America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
11.2.1 South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
11.2.2 South America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
11.3 Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.4 Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.5 Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11.6 Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Triad Isotopes, Inc. (US)
12.1.1 Triad Isotopes, Inc. (US) Basic Information
12.1.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.1.3 Triad Isotopes, Inc. (US) Production, Value, Price, Gross Margin 2015-2020
12.2 Medi-Radiopharma Ltd (Hungary)
12.2.1 Medi-Radiopharma Ltd (Hungary) Basic Information
12.2.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.2.3 Medi-Radiopharma Ltd (Hungary) Production, Value, Price, Gross Margin 2015-2020
12.3 Advanced Medical Isotope Corporation (US)
12.3.1 Advanced Medical Isotope Corporation (US) Basic Information
12.3.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.3.3 Advanced Medical Isotope Corporation (US) Production, Value, Price, Gross Margin 2015-2020
12.4 Alliance Medical (UK)
12.4.1 Alliance Medical (UK) Basic Information
12.4.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.4.3 Alliance Medical (UK) Production, Value, Price, Gross Margin 2015-2020
12.5 Peregrine Pharmaceuticals, Inc. (US)
12.5.1 Peregrine Pharmaceuticals, Inc. (US) Basic Information
12.5.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.5.3 Peregrine Pharmaceuticals, Inc. (US) Production, Value, Price, Gross Margin 2015-2020
12.6 Actinium Pharmaceuticals Inc (US)
12.6.1 Actinium Pharmaceuticals Inc (US) Basic Information
12.6.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.6.3 Actinium Pharmaceuticals Inc (US) Production, Value, Price, Gross Margin 2015-2020
12.7 Ion Beam Applications S.A (Belgium)
12.7.1 Ion Beam Applications S.A (Belgium) Basic Information
12.7.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.7.3 Ion Beam Applications S.A (Belgium) Production, Value, Price, Gross Margin 2015-2020
12.8 Mallinckrodt Pharmaceuticals (Ireland)
12.8.1 Mallinckrodt Pharmaceuticals (Ireland) Basic Information
12.8.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.8.3 Mallinckrodt Pharmaceuticals (Ireland) Production, Value, Price, Gross Margin 2015-2020
12.9 Siemens Healthcare (US)
12.9.1 Siemens Healthcare (US) Basic Information
12.9.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.9.3 Siemens Healthcare (US) Production, Value, Price, Gross Margin 2015-2020
12.10 Jubilant Pharma (India)
12.10.1 Jubilant Pharma (India) Basic Information
12.10.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.10.3 Jubilant Pharma (India) Production, Value, Price, Gross Margin 2015-2020
12.11 Positron Corporation (US)
12.11.1 Positron Corporation (US) Basic Information
12.11.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.11.3 Positron Corporation (US) Production, Value, Price, Gross Margin 2015-2020
12.12 Bayer HealthCare Medical Care (US)
12.12.1 Bayer HealthCare Medical Care (US) Basic Information
12.12.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.12.3 Bayer HealthCare Medical Care (US) Production, Value, Price, Gross Margin 2015-2020
12.13 Bracco Imaging S.p.A (Italy)
12.13.1 Bracco Imaging S.p.A (Italy) Basic Information
12.13.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.13.3 Bracco Imaging S.p.A (Italy) Production, Value, Price, Gross Margin 2015-2020
12.14 Nordion, Inc. (Canada)
12.14.1 Nordion, Inc. (Canada) Basic Information
12.14.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.14.3 Nordion, Inc. (Canada) Production, Value, Price, Gross Margin 2015-2020
12.15 Lantheus Medical Imaging Inc (US)
12.15.1 Lantheus Medical Imaging Inc (US) Basic Information
12.15.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.15.3 Lantheus Medical Imaging Inc (US) Production, Value, Price, Gross Margin 2015-2020
12.16 Avid Radiopharmaceuticals (US)
12.16.1 Avid Radiopharmaceuticals (US) Basic Information
12.16.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.16.3 Avid Radiopharmaceuticals (US) Production, Value, Price, Gross Margin 2015-2020
12.17 Immunomedics, Inc. (US)
12.17.1 Immunomedics, Inc. (US) Basic Information
12.17.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.17.3 Immunomedics, Inc. (US) Production, Value, Price, Gross Margin 2015-2020
12.18 Cardinal Health, Inc (US)
12.18.1 Cardinal Health, Inc (US) Basic Information
12.18.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.18.3 Cardinal Health, Inc (US) Production, Value, Price, Gross Margin 2015-2020
12.19 Alseres Pharmaceuticals, Inc (US)
12.19.1 Alseres Pharmaceuticals, Inc (US) Basic Information
12.19.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.19.3 Alseres Pharmaceuticals, Inc (US) Production, Value, Price, Gross Margin 2015-2020
12.20 GE Healthcare (UK)
12.20.1 GE Healthcare (UK) Basic Information
12.20.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction
12.20.3 GE Healthcare (UK) Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast
14.1 Global Nuclear Medicine-Radiopharmaceuticals Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Diagnostic Medicine Market Value and Volume Forecast (2020-2025)
14.1.2 Therapeutic Medicine Market Value and Volume Forecast (2020-2025)
14.2 Global Nuclear Medicine-Radiopharmaceuticals Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 SPECT Market Value and Volume Forecast (2020-2025)
14.2.2 PET Market Value and Volume Forecast (2020-2025)
14.2.3 Therapeutic Market Value and Volume Forecast (2020-2025)
14.3 Nuclear Medicine-Radiopharmaceuticals Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
?
List of Tables and Figures
Figure Product Picture of Nuclear Medicine-Radiopharmaceuticals
Table Product Specification of Nuclear Medicine-Radiopharmaceuticals
Table Nuclear Medicine-Radiopharmaceuticals Key Market Segments
Table Key Players Nuclear Medicine-Radiopharmaceuticals Covered
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size, 2015 - 2025
Table Different Types of Nuclear Medicine-Radiopharmaceuticals
Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) Segment by Type from 2015-2020
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Types in 2019
Table Different Applications of Nuclear Medicine-Radiopharmaceuticals
Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) Segment by Applications from 2015-2020
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Applications in 2019
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Regions in 2019
Figure North America Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Nuclear Medicine-Radiopharmaceuticals
Table Upstream Raw Material Suppliers of Nuclear Medicine-Radiopharmaceuticals with Contact Information
Table Major Players Headquarters, and Service Area of Nuclear Medicine-Radiopharmaceuticals
Figure Major Players Production Value Market Share of Nuclear Medicine-Radiopharmaceuticals in 2019
Table Major Players Nuclear Medicine-Radiopharmaceuticals Product Types in 2019
Figure Production Process of Nuclear Medicine-Radiopharmaceuticals
Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
Figure Channel Status of Nuclear Medicine-Radiopharmaceuticals
Table Major Distributors of Nuclear Medicine-Radiopharmaceuticals with Contact Information
Table Major Downstream Buyers of Nuclear Medicine-Radiopharmaceuticals with Contact Information
Table Global Nuclear Medicine-Radiopharmaceuticals Value ($) by Type (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Value Share by Type (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Value Share by Type (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Production by Type (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate of Diagnostic Medicine (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate of Therapeutic Medicine (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption by Application (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of SPECT (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of PET (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of Therapeutic (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2015
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2019
Figure North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table North America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table North America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table North America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure India Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Middle East Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Middle East Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Top 3 Market Share of Nuclear Medicine-Radiopharmaceuticals Companies in 2019
Figure Top 6 Market Share of Nuclear Medicine-Radiopharmaceuticals Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Triad Isotopes, Inc. (US) Profile
Table Triad Isotopes, Inc. (US) Product Introduction
Figure Triad Isotopes, Inc. (US) Production and Growth Rate
Figure Triad Isotopes, Inc. (US) Value ($) Market Share 2015-2020
Table Medi-Radiopharma Ltd (Hungary) Profile
Table Medi-Radiopharma Ltd (Hungary) Product Introduction
Figure Medi-Radiopharma Ltd (Hungary) Production and Growth Rate
Figure Medi-Radiopharma Ltd (Hungary) Value ($) Market Share 2015-2020
Table Advanced Medical Isotope Corporation (US) Profile
Table Advanced Medical Isotope Corporation (US) Product Introduction
Figure Advanced Medical Isotope Corporation (US) Production and Growth Rate
Figure Advanced Medical Isotope Corporation (US) Value ($) Market Share 2015-2020
Table Alliance Medical (UK) Profile
Table Alliance Medical (UK) Product Introduction
Figure Alliance Medical (UK) Production and Growth Rate
Figure Alliance Medical (UK) Value ($) Market Share 2015-2020
Table Peregrine Pharmaceuticals, Inc. (US) Profile
Table Peregrine Pharmaceuticals, Inc. (US) Product Introduction
Figure Peregrine Pharmaceuticals, Inc. (US) Production and Growth Rate
Figure Peregrine Pharmaceuticals, Inc. (US) Value ($) Market Share 2015-2020
Table Actinium Pharmaceuticals Inc (US) Profile
Table Actinium Pharmaceuticals Inc (US) Product Introduction
Figure Actinium Pharmaceuticals Inc (US) Production and Growth Rate
Figure Actinium Pharmaceuticals Inc (US) Value ($) Market Share 2015-2020
Table Ion Beam Applications S.A (Belgium) Profile
Table Ion Beam Applications S.A (Belgium) Product Introduction
Figure Ion Beam Applications S.A (Belgium) Production and Growth Rate
Figure Ion Beam Applications S.A (Belgium) Value ($) Market Share 2015-2020
Table Mallinckrodt Pharmaceuticals (Ireland) Profile
Table Mallinckrodt Pharmaceuticals (Ireland) Product Introduction
Figure Mallinckrodt Pharmaceuticals (Ireland) Production and Growth Rate
Figure Mallinckrodt Pharmaceuticals (Ireland) Value ($) Market Share 2015-2020
Table Siemens Healthcare (US) Profile
Table Siemens Healthcare (US) Product Introduction
Figure Siemens Healthcare (US) Production and Growth Rate
Figure Siemens Healthcare (US) Value ($) Market Share 2015-2020
Table Jubilant Pharma (India) Profile
Table Jubilant Pharma (India) Product Introduction
Figure Jubilant Pharma (India) Production and Growth Rate
Figure Jubilant Pharma (India) Value ($) Market Share 2015-2020
Table Positron Corporation (US) Profile
Table Positron Corporation (US) Product Introduction
Figure Positron Corporation (US) Production and Growth Rate
Figure Positron Corporation (US) Value ($) Market Share 2015-2020
Table Bayer HealthCare Medical Care (US) Profile
Table Bayer HealthCare Medical Care (US) Product Introduction
Figure Bayer HealthCare Medical Care (US) Production and Growth Rate
Figure Bayer HealthCare Medical Care (US) Value ($) Market Share 2015-2020
Table Bracco Imaging S.p.A (Italy) Profile
Table Bracco Imaging S.p.A (Italy) Product Introduction
Figure Bracco Imaging S.p.A (Italy) Production and Growth Rate
Figure Bracco Imaging S.p.A (Italy) Value ($) Market Share 2015-2020
Table Nordion, Inc. (Canada) Profile
Table Nordion, Inc. (Canada) Product Introduction
Figure Nordion, Inc. (Canada) Production and Growth Rate
Figure Nordion, Inc. (Canada) Value ($) Market Share 2015-2020
Table Lantheus Medical Imaging Inc (US) Profile
Table Lantheus Medical Imaging Inc (US) Product Introduction
Figure Lantheus Medical Imaging Inc (US) Production and Growth Rate
Figure Lantheus Medical Imaging Inc (US) Value ($) Market Share 2015-2020
Table Avid Radiopharmaceuticals (US) Profile
Table Avid Radiopharmaceuticals (US) Product Introduction
Figure Avid Radiopharmaceuticals (US) Production and Growth Rate
Figure Avid Radiopharmaceuticals (US) Value ($) Market Share 2015-2020
Table Immunomedics, Inc. (US) Profile
Table Immunomedics, Inc. (US) Product Introduction
Figure Immunomedics, Inc. (US) Production and Growth Rate
Figure Immunomedics, Inc. (US) Value ($) Market Share 2015-2020
Table Cardinal Health, Inc (US) Profile
Table Cardinal Health, Inc (US) Product Introduction
Figure Cardinal Health, Inc (US) Production and Growth Rate
Figure Cardinal Health, Inc (US) Value ($) Market Share 2015-2020
Table Alseres Pharmaceuticals, Inc (US) Profile
Table Alseres Pharmaceuticals, Inc (US) Product Introduction
Figure Alseres Pharmaceuticals, Inc (US) Production and Growth Rate
Figure Alseres Pharmaceuticals, Inc (US) Value ($) Market Share 2015-2020
Table GE Healthcare (UK) Profile
Table GE Healthcare (UK) Product Introduction
Figure GE Healthcare (UK) Production and Growth Rate
Figure GE Healthcare (UK) Value ($) Market Share 2015-2020
Table Market Driving Factors of Nuclear Medicine-Radiopharmaceuticals
Table Merger, Acquisition and New Investment
Table Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) Forecast, by Type
Table Global Nuclear Medicine-Radiopharmaceuticals Market Volume Forecast, by Type
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Diagnostic Medicine (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Diagnostic Medicine (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Therapeutic Medicine (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Therapeutic Medicine (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of SPECT (2020-2025)
Figure Market Volume and Growth Rate Forecast of SPECT (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of PET (2020-2025)
Figure Market Volume and Growth Rate Forecast of PET (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Therapeutic (2020-2025)
Figure Market Volume and Growth Rate Forecast of Therapeutic (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter's Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Global Surgical Overalls Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030.
According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
Global Medical or Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
Global Hospital Gas Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Nurse Call Systems Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 135
According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period.
The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
Global Pediatric Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 118
According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 100
Market Overview of Global Telepharmacy market:
According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Vinca Alkaloid Compounds market:
According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 116
Market Overview of Global Bladder Cancer market:
According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years.
Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market:
According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
